|02:30 PM - 03:30 PM ET|
|01:30 PM - 02:30 PM CT|
|11:30 AM - 12:30 PM PT|
As part of the global fight against coronavirus (COVID-19), FDA is working closely with medical product sponsors and investigators to find a potential treatment. As part of these efforts, multiple FDA expedited pathways may be available to the medical product industry and healthcare providers for the study and use of COVID-19 treatments. Join us for a presentation discussing those pathways.
CLE credit: CLE credit in CA, IL, MA, NJ (via reciprocity), NY, PA, TX, and VA is currently pending approval.